VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0962122
Sex: F
Age:
State: CO

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Very sleepy 4 hours after second dose; This is a spontaneous report from a contactable healthcare professional (patient herself). A 60-year-old female patient received the second dose of bnt162b2 (lot number: Ek9231), intramuscularly on the left arm on 11Jan2021 09:30 at a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient was not pregnant. The patient had no COVID prior vaccination. The patient was not COVID tested post vaccination. The patient has no known allergies. The patient previously took the first dose of BNT162B2 (lot number: Ek5730) intramuscularly on the right arm on 22Dec2020 at 08:00 AM. On 11Jan2021 14:00, the patient became very sleepy four hours after second dose. The patient was recovering from the event. No treatment was given in response to very sleepy 4 hours after second dose.

Other Meds:

Current Illness:

ID: 0962123
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: Covid virus; Test Result: Positive ; Comments: positive for the Covid virus.

Allergies:

Symptoms: positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a contactable nurse (patient) received via Medical Information Team. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received the first dose then tested positive for the COVID-19 virus, on an unspecified date. The patient underwent lab tests and procedures which included SARS-COV-2 test: positive. The patient outcome of the event was unknown. The information on the batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 virus test positive and suspected LOE due to temporal relationship. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0962124
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: her lymph nodes are swelling after the administration of the second dose of the Pfizer's COVID-19 vaccine.; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date to a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the consumer reported that her lymph nodes are swelling after the administration of the second dose of the Pfizer's COVID-19 vaccine. The outcome of the event was unknown. No follow-up attempts are possible. Information regarding Lot/Batch/Expiry date could not be requested. No further information is expected.

Other Meds:

Current Illness:

ID: 0962125
Sex: M
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hiccups; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at single fdose for COVID-19 immunization. The patient 's medical history and concomitant medications were not reported. The patient experienced hiccups on 10Jan2021 after eating dinner that lasted until he went to sleep, over an hour. Patient was wondering if this is a known side effect of the vaccine and/or Covid. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962126
Sex: M
Age:
State: AZ

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: weighs; Result Unstructured Data: Test Result:200-202 lbs

Allergies:

Symptoms: he felt "very hot" ("felt like a heatlash"); itchy ("sandpapery") throat; This is a spontaneous report from a contactable consumer. A 25-year-old male patient received first dose of bnt162b2 (BNT162B2; lot number: EK5730), via an unspecified route of administration on 23Dec2020 at a single dose for covid-19 immunisation/ work. The patient has no medical history and concomitant medications. On 23Dec2020, the patient reported right after the first shot he had to wait 15 minutes for reaction-based purposes. Once he got to his car, the patient felt really really hot, and his throat started to itch described as was "sandpapery". It wasn't horrible. It was not like anaphylactic. The patient took 2 antihistamine tablets (Benadryl), and it went away. He has had no AE since. The outcome of the events was recovered on 23Dec2020.

Other Meds:

Current Illness:

ID: 0962127
Sex: F
Age:
State: MI

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Occasional chills; mild chest pain with deep breath; mild chest pain with deep breath; This is a spontaneous report from a contactable consumer (reporting for a patient). A 46-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on the left arm on 08Jan2021 12:00 at a single dose for COVID-19 immunization. There was no other medical history, had no known allergies. Concomitant medications were not reported. The patient did not have COVID and did not receive other vaccine in four weeks prior to vaccination; did not have other medication within two weeks and was not pregnant at the time of vaccination. On 08Jan2021, the patient experienced occasional chills and mild chest pain with deep breath. No treatment was given for the events. The patient has not been tested for COVID post-vaccination. Outcome of the events was recovered on an unspecified date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962128
Sex: F
Age:
State: OR

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; chills; lethargy; body aches; headache that kicked in 12 hours; This is a spontaneous report from a contactable healthcare professional. A 29-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231, expiry date not reported), via an unspecified route of administration in the left arm on 09Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to and post vaccination. Since the vaccination, the patient has not been tested for COVID-19. On 09Jan2021, the patient experienced fever, chills, lethargy, body aches, and headache that kicked in 12 hours after the vaccination and lasted for 24 hours. Clinical outcome of the events was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 0962129
Sex: F
Age:
State: CA

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain and numbness in arm of injection; Pain and numbness in arm of injection; This is a spontaneous report from a contactable consumer. A 47-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El1282 and expiration date not provided), via an unspecified route of administration in the left arm on 11Jan2021 12:00 at a single dose for COVID-19 immunization. Medical history included diabetes mellitus. The patient was not pregnant at the time of vaccination. The patient had no known allergies. Concomitant medications included metformin, lisinopril, and aspirin (ACETYLSALICYLIC ACID). The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 11Jan2021 14:00, the patient experienced pain and numbness in arm of injection. Treatment was not provided in response to the events. The outcome of the events was not recovered. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since vaccination.

Other Meds: ; ; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 0962130
Sex: M
Age:
State: FL

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe right tibialis anterior muscle cramp; low level fever; This is a spontaneous report from a contactable physician (patient). This 43-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899 and expiry date unknown, vaccine location: left arm), intramuscular on 05Jan2021 08:00 at a single dose for COVID-19 immunization. Medical history included hypertension. The patient has no known allergies. Concomitant medication included valsartan and loratadine (other medications in two weeks include valsartan and loratadine). The patient took the first dose of bnt162b2 on 16Dec2020 01:00 PM (lot number: EH9899) intramuscular, vaccine location: left arm. The patient experienced severe right tibialis anterior muscle cramp on 06Jan2021 12:00 PM, 30 hours after second injection (as reported) with onset of low level fever. The fever resolved within 2 hours. Muscle cramping persisted for 30 hours with complete resolution. No treatment was received. Outcome of the event low level fever was recovered on 06Jan2021 14:00 and of the event muscle severe right tibialis anterior muscle cramp was recovered on 07Jan2021 18:00. The patient had no COVID prior to vaccination. The patient was not tested for COVID post-vaccination. The patient had no other vaccine in four weeks.

Other Meds: ;

Current Illness:

ID: 0962131
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:fever; Test Name: neurologist general physical exam; Result Unstructured Data: Test Result:normal

Allergies:

Symptoms: fever and malaise 1st couple of days after her COVID vaccine.; fever and malaise 1st couple of days after her COVID vaccine.; On day 3-10, experienced 'paresthesia felt like polyneuropathy in hand, right foot, muscles, felt like shooting electric shocks in both hands. It felt like she had been applying 'pressure on nerves'; On day 3-10, experienced 'paresthesia felt like polyneuropathy in hand, right foot, muscles, felt like shooting electric shocks in both hands. It felt like she had been applying 'pressure on nerves'; This is a spontaneous report from a contactable Physician reporting for herself. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Medical history included COVID-19 from Feb2020. The patient's concomitant medications were not reported. The patient reported fever and malaise 1st couple of days after her COVID vaccine. On day 3-10, she experienced 'paresthesia, felt like polyneuropathy in her hand, right foot, muscles, felt like shooting electric shocks in both hands. It felt like she had been applying 'pressure on nerves'. Has since resolved completely. She has seen a neurologist who performed a general physical exam and it appeared normal. Also, she notified or asked Nursing occupational health. She had a history of COVID last Feb2020. She was asking if there are any recommendation if she should get the 2nd dose of the COVID vaccine. The events had resolved. Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event polyneuropathy cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0962132
Sex: F
Age:
State: ID

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: yeast infection; This is a spontaneous report from a contactable healthcare professional (reported for herself). A 36-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL0140; expiry date: not known), intramuscular on 18Dec2020 and second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL3246; expiry date: not known), via an unspecified route of administration on 08Jan2021, both in the right arm at single dose for COVID-19 immunization, administered in hospital. There was no medical history. No known allergies. The patient is not pregnant. Concomitant medications included ibuprofen (ADVIL), dextromethorphan hydrobromide, guaifenesin, paracetamol, pseudoephedrine hydrochloride (DAYQUIL), and valaciclovir hydrochloride (VALACYCLOVIR) (medications received in two weeks). The patient had no COVID prior vaccination and not tested post vaccination. The patient experienced yeast infection on 19Dec2020. This event got by the patient for both doses. No treatment received for this event. The outcome of the event was recovered on an unspecified date.

Other Meds: ADVIL [IBUPROFEN]; DAYQUIL; VALACYCLOVIR [VALACICLOVIR HYDROCHLORIDE]

Current Illness:

ID: 0962133
Sex: F
Age:
State: OR

Vax Date: 01/10/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore area at injection site when touched; very slight sore throat; very slight headache; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EK9231, expiry date unknown), via an unspecified route of administration on the left arm on 10Jan2021 05:00 AM at single dose for COVID-19 immunization. The patient's medical history included asthma, seasonal allergy, and hypothyroid, all from an unknown date. The patient is not pregnant. Concomitant medications included levothyroxine, diphenhydramine hydrochloride (BENADRYL), and basic vitamins; patient also received these medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Jan2021 04:45 AM, the patient experienced sore area at injection site when touched, very slight sore throat and very slight headache. No therapeutic measures were taken in response to the events. Outcome of the events at the time of last observation was recovering. The events were assessed as non-serious. Information on the lot/batch number has been obtained.

Other Meds: ; BENADRYL

Current Illness:

ID: 0962134
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: temperature; Result Unstructured Data: Test Result:ok

Allergies:

Symptoms: lightheaded; tingling in her fingers; feverish but my temperature was ok; night sweats; This is a spontaneous report from a contactable consumer (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had COVID vaccine and experienced a couple of side effects two days after getting the vaccine which lasted 3 days. On an unspecified date, she was lightheaded and had this random tingling in her fingers. She also felt feverish but her temperature was ok but she was also feeling like she was having night sweats. She got a first dose of the vaccine at 2pm on Wednesday, then she woke up on Friday morning and felt, everything was like subtle, and did not feel like she had to stay at home. She could go to work, was just how she felt. Sometimes it felt like it was just in her head but then by 5 or 6 days later, that Monday or Tuesday morning she woke up and everything was gone and back to normal. Outcome of the events was recovered on an unspecified date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962135
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: has an itchy rash on her legs; has lots of red dots on the bottom part of her legs that's really itchy; is going crazy; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history included kind of itchy before the first Pfizer COVID vaccine. Concomitant medications were not reported. On an unspecified date, the patient experienced an itchy rash on her legs. The patient received the Pfizer COVID vaccine and was not sure if this issue was related with it, but had lots of red dots on the bottom part of her legs The patient reported she was going crazy and that it was really itchy. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0962136
Sex: F
Age:
State: FL

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Insomnia; This is a spontaneous report from a contactable consumer (patient). An 84-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 13:00 at a single dose for COVID-19 immunization at a Public Health Department. The patient's medical history and concomitant medications were not reported. The patient experienced insomnia on 10Jan2021 01:00 with outcome of not recovered. No treatment was given for the event. Patient is not pregnant. The patient was not diagnosed of COVID prior vaccination and has not tested for COVID post vaccination. Information about Lot/Batch number is requested.

Other Meds:

Current Illness:

ID: 0962137
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; Chills; Total body aching; Nausea; Headache; Tiredness; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142), via an unspecified route of administration (left arm) on 08Jan2021 (07:45) at single dose for Covid-19 immunization. Medical history included kidney reflux as child, gallbladder removal at 18, and known allergies: rubber allergies, lactose intolerant, and seasonal allergies. Concomitant medications included ascorbic acid (VITAMIN C) and Multivitamins (ritual women 2 a day). The patient previously received the first dose of BNT162B2 (lot number: EK5730) on 18Dec2020 (06:00 AM) via an unspecified route (left arm) for Covid-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Jan2021 (21:00), patient experienced chills, total body aching, nausea, headache, tiredness; and fever for about 24 hours starting about 18 hours after received the vaccine on 09Jan2021 (01:45). It was reported that it was hard to keep the fever down with just Tylenol, the patient needed to take ibuprofen. There was no treatment received for the other adverse event. The outcome of events was recovered with lasting effects (unspecified date). The patient has not been tested for COVID-19 since the vaccination.

Other Meds: VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 0962138
Sex: F
Age:
State: IL

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild nausea; Flu-like symptoms; headache; mild dizziness; mild brain fog mid afternoon; having some sensitivity to sound and light; having some sensitivity to sound and light; I'm suspecting this may be triggering a migraine; This is a spontaneous report from a contactable other healthcare professional (hcp reporting for herself). A 38-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot EL1283, expiry date not reported), via an unspecified route of administration on 09Jan2021 07:00 at a single dose on the left arm for COVID 19 immunization. Medical history included GERD (gastrooesophageal reflux disease), migraines, and indoor allergies. The patient was not pregnant at the time of the vaccination. The patient had no Covid prior to vaccination. Concomitant medication included mometasone furoate (FLONASE), taken within two week prior to vaccination. The patient previously took codeine and was allergic to it; and flu vaccine and experienced intolerance and short term dizziness. Patient had first dose of Pfizer COVID 19 bnt162b2 as COVID 19 immunization on 19Dec2020 at 07:30 AM, intramuscularly on the left arm. No other vaccines were taken in the four weeks. Patient received second Pfizer dose on Saturday (09Jan2021) at approximately 7:00am. Consistent with prior history of dizziness following flu vaccines, patient started to develop mild dizziness and mild brain fog mid afternoon (reported as 09Jan2021 11:30). Flu-like symptoms and headache started around 8:00pm and resolved around 6:00pm on Sunday (the following day; 10Jan2021). Mild nausea also experienced Sunday morning (10Jan2021). Unfortunately, patient was still experiencing dizziness and brain fog that comes and goes and was worse midafternoon. Patient was having some sensitivity to sound and light, and suspecting this may be triggering a migraine since 09Jan2021 11:30. As treatment to the reported events patient received Aleve. The patient was not tested for COVID post vaccination. The patient recovered from flu-like symptoms and headache on 10Jan2021 18:00. The patient had not recovered from mild dizziness, mild brain fog, mild nausea, some sensitivity to sound and light and migraine.

Other Meds: FLONASE [MOMETASONE FUROATE]

Current Illness:

ID: 0962139
Sex: M
Age:
State: NY

Vax Date: 01/10/2021
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:102

Allergies:

Symptoms: strong pulsating heartbeat; severe arm pain; fever with temperature of 102 [units unspecified]; abdominal pain; general weakness; unquenchable thirst; very bad headache; tiredness; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old male patient received his first dose of bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE; unknown lot number and expiration date), via an unspecified route of administration on 10Jan2021 10:00 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that he did not experience any symptoms yesterday (unspecified date) and a few hours ago, he started to experience severe arm pain, fever with of 102 [units unspecified], abdominal pain, general weakness, unquenchable thirst, very bad headache, tiredness and strong pulsating heartbeat. The outcome of the events was unknown. Information about lot/batch has been requested.

Other Meds:

Current Illness:

ID: 0962140
Sex: F
Age:
State: WA

Vax Date: 12/30/2020
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: treated as panic attack; having difficulty getting thoughts together; My arms were very numb and tingly; My arms were very numb and tingly; This is a spontaneous report from a non-contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number: EK5730, unknown lot number), via an unspecified route of administration in left arm on 30Dec2020 at 09:30 at a single dose for COVID-19 immunization. Medical history included prior history of panic attacks, HPV, and known allergies to pets and pollen. Concomitant medications included naproxen sodium (ALEVE), cyclobenzaprine, and aspirin. The patient was vaccinated in a hospital on 30Dec2020 at 09:30. The early morning of 06Jan2021 at 03:15 AM, the patient woke up with very alarming symptoms. She woke up very suddenly and was having difficulty getting thoughts together, her arms were very numb and tingly. She has had panic attacks before, and this did not feel like anything she had experienced. The events resulted in emergency room (ER)/department or urgent care visit. In ER, the patient treated as panic attack, no testing done. The patient was treated for the events. The patient did not have COVID prior to vaccination and the patient was not tested for COVID post vaccination. The patient did not have other vaccine in four weeks. The patient recovered from the events in Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds: ALEVE; ; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 0962141
Sex: M
Age:
State: PA

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: diastolic blood pressure; Result Unstructured Data: Test Result:(high 80's/low 90's) which is usually in 70's

Allergies:

Symptoms: Increased level of alertness; Difficulty falling asleep; Increased diastolic blood pressure(high 80's/low 90's) which is usually in 70's; feeling heart beat in chest; Minor anxious feeling; This is a spontaneous report from a contactable other HCP (patient). A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection, lot no: EK9231, expiry date: unknown), via unspecified route of administration on left arm on 05Jan2021 08:15 at a single dose (1st dose) for Covid-19 immunization. The patient received the vaccine in a hospital. There were no other vaccine administered in the last four weeks. The patient's medical history included penicillin allergies, seasonal asthma, and increased cholesterol. Concomitant medications included Fish oil, D3, Vitamin C, Bilberry, Chromium. On 05Jan2021 20:15, patient experienced increased level of alertness, difficulty falling asleep, increased diastolic blood pressure(high 80's/low 90's) which is usually in 70's feeling heart beat in chest and minor anxious feeling. There was no treatment given for all reported adverse events. It was unknwon if patient had COVID prior vaccination. Patient has not tested COVID post vaccination. The outcome of all events was recovering.

Other Meds: ; D3; VITAMIN C [ASCORBIC ACID]; BILBERRY [VACCINIUM MYRTILLUS];

Current Illness:

ID: 0962142
Sex: F
Age:
State: MA

Vax Date: 01/10/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210101; Test Name: Nasal Swab; Test Result: Negative ; Comments: tested for Covid post vaccination of the first dose

Allergies:

Symptoms: Headache; muscle cramps; chills; diarrhea; chest pain; This is a spontaneous report from a contactable nurse (patient). A 24-year-old non-pregnant female patient received second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL1284), via an unspecified route of administration in the left arm on 10Jan2021 at a single dose for COVID-19 immunization. The patient was vaccinated in a hospital facility. Medical history included irritable bowel syndrome (IBS), endometriosis, chronic headaches, birth control, and sulfonamide allergy (reported as known allergy to Sulfa). The patient had no Covid prior vaccination. Concomitant medications included montelukast and unspecified medication for birth control. The patient previously received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EJ1685) in the left arm on 20Dec2020 17:30 at a single dose for COVID-19 immunization. The patient was tested for Covid post vaccination of the first dose and had negative nasal swab on 01Jan2021. The patient did not receive any other vaccine in four weeks. The patient experienced headache, muscle cramps, chills, diarrhea, and chest pain on 11Jan2021. No treatment was received for the reported events. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0962143
Sex: F
Age:
State: WA

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: BP; Result Unstructured Data: Test Result:normal; Test Date: 20210111; Test Name: BP; Result Unstructured Data: Test Result:Elevated

Allergies:

Symptoms: BP elevated; Light headedness 24 minutes post shot; This is a spontaneous report from a contactable nurse (patient). A 36-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El1284), via an unspecified route of administration on 11Jan2021 15:15 at a single dose on right arm for COVID-19 immunization. Medical history included hypothyroidism, systemic mastocytosis and allergies to sulfa. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior to vaccination. The patient previously took fexofenadine hcl (ALLEGRA) and experienced allergies. The patient was administered with first dose of bnt162b2 on 21Dec2020 15:30 on right arm for COVID-19 immunization (lot number: El0140). No other vaccines received in four weeks prior to COVID vaccination. On 11Jan2021 15:39, the patient experienced light headedness 24 minutes post shot and BP (blood pressure) was elevated at 15:45. Patient laid on floor for 15-20 minutes and 49 minutes after shot, she felt so what back to normal with normal BP. No treatment was received for the adverse events. The patient has not been tested for COVID post vaccination. Patient recovered from BP elevated on 11Jan2021 at 16:04, and from light headedness on an unspecified date.

Other Meds:

Current Illness:

ID: 0962144
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: Nasal swab; Result Unstructured Data: Test Result:positive for covid

Allergies:

Symptoms: 10 days after receiving vaccine patient tested positive for covid via nasal swab; 10 days after receiving vaccine patient tested positive for covid via nasal swab; Mild cold symptoms; This is a spontaneous report from a contactable physician. A female patient of an unspecified age received her first dose of BNT162B2 (lot no. and expiry date were not reported), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of vaccine, and 10 days after receiving vaccine patient tested positive for covid via nasal swab on unspecified date. The patient also experienced mild cold symptoms on unspecified date. The physician would like to know if his patient should receive second dose or if any literature supports second dose after getting covid in between dose. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0962145
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hives all over her body; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced hives all over her body (non-serious) on an unspecified date with an outcome of unknown. No follow-up attempts are possible; information about batch/lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 0962146
Sex: F
Age:
State: MA

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; chills; body aches; Date of start of drug: 11Jan2021/ 12Dec2020; This is a spontaneous report from a contactable nurse (patient). A 40-years-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek9231, expiration date unknown), intramuscular on the left arm 11Jan2021 at 08:00 at a single dose and the first dose (lot number: Eh9899) via intramuscular on the left arm on 12Dec2020 at 08:00 at a single dose for COVID-19 immunization. Medical history included Known allergies to Latex and 1000 island dressing. The patient is not pregnant. The patient's concomitant medications were not reported. The patient previously received the first dose of bnt162b2 on 12Dec2020 for COVID-19 immunization and with which the patient experienced fever, chills and body aches. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient has no COVID prior vaccination and no COVID testing post vaccination. The patient experienced fever, chills, and body aches on 11Jan2021 at 20:00, 12 hours post vaccine. The events were resolving.

Other Meds:

Current Illness:

ID: 0962147
Sex: F
Age:
State: IL

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: few hives/rash; few hives/rash; This is a spontaneous report from a contactable healthcare professional (patient). A 33-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EK9231), via an unspecified route of administration in the left arm on 11Jan2021 at 15:00 at a single dose in the hospital for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not have COVID prior to vaccination. The patient was not pregnant at the time of report. The patient experienced few hives/rash on 11Jan2021 at 18:00, about 2 hours after getting the vaccine. The patient did not receive treatment for the events. The patient was not tested for COVID post vaccination. Outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0962148
Sex: F
Age:
State: MD

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: Fever; Result Unstructured Data: Test Result:100.2; Test Date: 20210109; Test Name: Fever; Result Unstructured Data: Test Result:101

Allergies:

Symptoms: chills; headache; fatigue; fever 101; body aches; This is a spontaneous report from a contactable healthcare professional (patient). A 60-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142), via an unspecified route of administration in right arm on 09Jan2021 11:00 at single dose for COVID-19 immunization. Medical history included hypothyroidismand arthritis from an unknown date and unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID), progesterone and estradiol (DOTTI). The patient previously took ace inhibitors and experienced allergies. The patient had first dose of BNT162B2, via unspecified route of administration on 18Dec2020 11:00 AM, lot number: EK507, in right arm at single dose for COVID-19 immunization. On 09Jan2021 2:30 AM, the patient woke up and experienced chills, fever 101, headache, fatigue and body aches and it lasted most of the day. The patient went back to bed at 8:30 PM and still had fever 100.2 and fatigue but most other symptoms getting better. The patient woke on 10Jan2021 at 4:30 am for work, no fever and some fatigue but that was it. No other reactions since this writing. The outcome of the event fever was recovered on 10Jan2021 and the outcome of the remaining events was recovering. No treatment was given for the events. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: SYNTHROID; ; DOTTI

Current Illness:

ID: 0962149
Sex: F
Age:
State: TN

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: GI upset; Cramping; Diarrhea; This is a spontaneous report from a contactable healthcare professional. A 39-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID 19 vaccine; unknown lot number and expiration date), via an unspecified route of administration right arm on 05Jan2021 06:30 at a single dose for covid-19 immunization. Medical history included lymphoma and was identified with Covid prior vaccination. The patient has not received other vaccines in four weeks. There were no concomitant medications. The patient previously took acetazolamide (DIAMOX) but had allergies. The patient received her vaccine in a hospital. The patient experienced GI (gastrointestinal) upset, cramping and diarrhea on 05Jan2021 13:00. No treatment was received for the adverse events. The patient has not been tested post vaccination. The outcome of the events was recovered on Jan2021. The following information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0962150
Sex: F
Age:
State: MA

Vax Date: 01/04/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash on her right forearm consisting of clusters of vesicles on an erythematous base; rash is consistent with a diagnosis of herpes zoster or shingles; Radiating burning pain down the underside or volar side of her right arm to her wrist; first felt like a bruise; Radiating burning pain down the underside or volar side of her right arm to her wrist; first felt like a bruise; Pain then began to feel more like a bad sunburn with her skin being tender in the same distribution; This is a spontaneous report from a contactable healthcare professional (patient). A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK9231), via an unspecified route of administration in right arm, on 04Jan2021 at 18:15, at a single dose, for COVID-19 immunization. The patient had no medical history and concomitant medications. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The facility where the vaccine was administered was her workplace clinic. On 05Jan2021 at 03:00 PM, the patient developed radiating burning pain down the underside or volar side of her right arm to her wrist (vaccinated arm) that at first felt like a bruise within 24 hours of receiving the vaccine. In Jan2021, the pain then began to feel more like a bad sunburn with her skin being tender in the same distribution. Then on 11Jan2021, the patient developed a rash on her right forearm consisting of clusters of vesicles on an erythematous base. The patient consulted with a dermatologist in her primary care physician who agreed that the rash is consistent with a diagnosis of herpes zoster or shingles. This resulted in doctor or other healthcare professional office or clinic visit. Treatment received for shingles included valacyclovir. Post-vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events.

Other Meds:

Current Illness:

ID: 0962151
Sex: F
Age:
State: OK

Vax Date: 12/15/2020
Onset Date: 12/15/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: temperature; Result Unstructured Data: Test Result:100.6; Test Name: temperature; Result Unstructured Data: Test Result:99.6; Test Date: 20201215; Test Name: temperature; Result Unstructured Data: Test Result:99.5; Test Date: 20201218; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Fever of 99.5; Body aches; chills; red face; feeling flushed 5 hours after 1st shot; Headache for next two days; This is a spontaneous report from a contactable other hcp (patient). A 30-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular on 15Dec2020 10:00 at single dose (Left arm) for COVID-19 immunization. Medical history included Covid 19. Patient is not pregnant. Patient had no known allergies. Concomitant medication included pseudoephedrine. Facility type vaccine: Hospital. There was no other vaccine in four weeks. On 15Dec2020 15:00, it was reported that patient had Fever of 99.5, body aches, chills, red face, and feeling flushed (5 hours after 1st shot). Temp increased to 100.6 so I took Aleve and I felt better in 30 min. Headache for next two days. After second shot, fever of 99.6 and body aches with chills after 12 hours. Took Aleve and fever was gone felt fine by noon next day. The patient underwent lab tests and procedures which included Nasal Swab: negative on 18Dec2020. Therapeutic measures were taken as a result of fever of 99.5. The outcome of the events was recovered on an unspecified date. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962152
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: eyes are swollen and itchy; eyes are swollen and itchy; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the second dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration on an unspecified date at a single dose as a COVID-19 vaccine. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine) on an unspecified date. The patient just got the second vaccine and experienced side effects as eyes were swollen and itchy on an unspecified date and had to take Claritin and Benadryl. There was no swelling of the face/tongue. The patient was asking if this was normal and what should they do. Outcome of the events was unknown. Information about the lot/batch has been requested.

Other Meds:

Current Illness:

ID: 0962153
Sex: F
Age:
State: MO

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lymphadenitis developed in my axilla and extended down my right chest wall.; This is a spontaneous report from a contactable nurse (patient). A 51-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration in the right arm on 08Jan2021 10:45 at a single dose for COVID-19 immunization. There were no medical history. The patient had no known allergies to medications, food, or other products. The patient was not pregnant. Concomitant medication included levothyroxine sodium (SYNTHROID). The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left arm on 29Dec2020 at the age of 51 years old for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced lymphadenitis developed in her axilla and extended down her right chest wall on 09Jan2021. No treatment was received for the adverse event. Outcome of the event was recovering. Information about batch/lot number has been requested.

Other Meds: SYNTHROID

Current Illness:

ID: 0962154
Sex: U
Age:
State: TN

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210106; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative; Comments: post vaccination

Allergies:

Symptoms: Rash; fever; severe chills; head ache/head ache lingering 6 days after; joint pain; kidney pain; lethargy; difficulty concentrating; This is a spontaneous report from a contactable nurse. A 46-year-old patient of an unspecified gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date unspecified), intramuscular on 06Jan2021 at single dose (right arm) for COVID-19 immunization. Medical history included celiac disease and allergies: gluten. The patient's concomitant medications were not reported. On 06Jan2021, the patient experienced rash, fever, severe chills, headache, joint pain, kidney pain, lethargy, and difficulty concentrating. The main symptoms lasted about 48 hours, and headache was lingering 6 days after. There was no therapy for the events. There were no other vaccine in four weeks and no other medications in two weeks. The patient underwent lab tests and procedures which included nasal swab was negative on 06Jan2021, post vaccination. Outcome of event head ache/head ache lingering 6 days after was recovering; outcome of the rest of events was recovered on 08Jan2021. Information about Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0962155
Sex: F
Age:
State: KY

Vax Date: 12/18/2020
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Approx. 2x2: painful, red, warm, raised area at injection site; Approx. 2x2: painful, red, warm, raised area at injection site; Approx. 2x2: painful, red, warm, raised area at injection site; This is a spontaneous report from a contactable nurse (patient herself). A 29-year-old female patient received two doses of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), first dose on 18Dec2020 (lot number: EK5730) and second dose on 08Jan2021 (lot number: EK9231), both intramuscular in the left arm (injection placed approximately 8" below acromion process, medial side of arm, not into deltoid) at single dose for COVID-19 immunization. Medical history included asthma and covid (reported as "if covid prior vaccination: Yes"). The patient is not pregnant. Concomitant medications included montelukast sodium (SINGULAIR), sertraline hydrochloride (ZOLOFT), and melatonin. The patient previously took phenytoin sodium (DILANTIN) and carbamazepine (TEGRETOL), and both experienced with known allergies. The patient had not tested for COVID post vaccination. The patient experienced approx. 2x2: painful, red, warm, raised area at injection site on 09Jan2021 04:00. No treatment received for these events. The outcome of the events was recovering.

Other Meds: SINGULAIR; ZOLOFT;

Current Illness:

ID: 0962156
Sex: F
Age:
State: MO

Vax Date: 01/03/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swelling and itching at injection site; Swelling and itching at injection site; This is a spontaneous report from a contactable pharmacist (patient). A 44-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number:EL1284) via an unspecified route of administration into the left arm on 03Jan2021 12:45 at a single dose for covid-19 immunisation. Medical history included hypothyroidism and hyper cholesterol. The patient's concomitant medications were not reported. The patient experienced swelling and itching at injection site on 11Jan2021 20:00. The patient did not receive treatment and was not pregnant. Outcome of events was not recovered.

Other Meds:

Current Illness:

ID: 0962157
Sex: F
Age:
State: IA

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; arm pain; This is a spontaneous report from a contactable healthcare professional (reporting for herself) via Pfizer and Medical information team. A female patient of an unspecified age (Age: 23; Units: unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of vaccine today on 11Jan2021 and patient would like to know if she can take Ibuprofen or Tylenol for the headache and arm pain she experienced in Jan2021. The patient stated, "I read on my transact sheet that they say that you are not supposedly to take like ibuprofen before you get the second vaccine. If I have a headache can I take something or should I not?". The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962158
Sex: F
Age:
State: FL

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: "hot flashes" in the middle of the night. She also mentioned that the same thing happened last night.; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unknown route of administration on 09Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient said she received the 1st dose of the bnt162b2 last Saturday. However, she said that after receiving the 1st dose of the vaccine, she started to experience "hot flashes" in the middle of the night. She also mentioned that the same thing happened last night. Patient wanted to know if this was normal. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962159
Sex: F
Age:
State: AZ

Vax Date: 01/10/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: Temperature; Result Unstructured Data: Test Result:100.5 Fahrenheit

Allergies:

Symptoms: sore arm; She is experiencing a temperature of 100.5 F; This is a spontaneous report from a contactable consumer reported for herself. A female patient of an unspecified age (reported as 63, unit unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date unknown), via an unspecified route of administration on 10Jan2021 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received first dose on Sunday. She is experiencing a temperature of 100.5 F and a sore arm today on 11Jan2021. The patient would like to know what she should do. The outcome of the events was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0962160
Sex: F
Age:
State: TX

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: brain fog; intense headache; muscle aches; stomach pain; fatigue; 2nd dose on 06Jan2021; This is a spontaneous report from a contactable healthcare professional (patient). A 27-year-old female patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular left arm on 06Jan2021 15:00 at single dose for COVID-19 immunization. Medical history included milk allergy. Patient was not pregnant. There were no concomitant medications. The patient took the 1st dose of BNT162B2 on 23Dec2020 15:30 (left arm). The patient experienced 5 days ongoing brain fog, intense headache, muscle aches, stomach pain, and fatigue on 06Jan2021 21:00. Outcome of the events of brain fog, headache, muscles aches, stomach pain and fatigue was not recovered. No treatment was given for the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962161
Sex: F
Age:
State: CA

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Right side neck stiffness; small area on lower left arm itching (no rash); tenderness right side sternum and pec muscle; tenderness right side sternum and pec muscle; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EJ1686), via an unspecified route of administration in left arm on 11Jan2021 07:15 in a hospital at a single dose for COVID-19 immunization. Medical history included known allergies with CT contrasting agent, walnuts, pecans, patient also has high blood pressure, pre-diabetes, and depressive disorder. Concomitant medications included hydrochlorothiazide and lisinopril. The patient previously took (promethazine hydrochloride) REGAN and carbomer and experienced allergies. The patient experienced right side neck stiffness, small area on lower left arm itching (no rash), tenderness right side sternum and pec muscle on 11Jan2021 19:30. The patient was not pregnant. The patient does not have COVID prior vaccination. Patient was not tested for COVID post vaccination. No treatment was received for the adverse event. The outcome of the events was recovering.

Other Meds: ;

Current Illness:

ID: 0962162
Sex: M
Age:
State: MA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: Nasal Swab; Test Result: Negative ; Comments: covid test result=Negative

Allergies:

Symptoms: diffuse urticaria on my trunk and face/had recurrent diffuse urticaria, predominantly in the face; Associated with itching; mild abdominal discomfort; facial flushing; Persistent intermittent sweats, and significant fatigue; Persistent intermittent sweats, and significant fatigue; first dose given on 21Dec2020 and second dose on 07Jan2021 (Day 18); This is a spontaneous report from a contactable physician (reported for himself). A 30-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 07Jan2021 17:00 at a single dose on left arm for COVID-19 immunization. Medical history included allergies to shellfish. The patient was not diagnosed with COVID prior to vaccination. Concomitant medications were not reported. The patient received first dose of bnt162b2 on 21Dec2020 on left arm for COVID-19 immunization (lot number: EH9899). No any other vaccines within 4 weeks prior to the COVID vaccine. On 10Jan2021 18:00 (three days after second immunization), the patient developed diffuse urticaria on his trunk and face, associated with itching, mild abdominal discomfort, and facial flushing. Symptoms somewhat improved with cetirizine. About 24 hours later, he had recurrent diffuse urticaria, predominantly in the face, persistent intermittent sweats, and significant fatigue. Treatment was given to the patient for the adverse events. The patient underwent lab tests and procedures which included nasal swab (COVID test type post vaccination): negative on 11Jan2021. The patient has not recovered from the events.

Other Meds:

Current Illness:

ID: 0962163
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Disseminated Granuloma annular; My entire body was covered by the lesions; Leaving my skin damaged in many places; became allergic to many food and preservatives; became allergic to many food and preservatives; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient) from the Pfizer-sponsored program. A 73-year-old female patient received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) (Manufacturer: Pfizer, lot number and expiration date unknown), and influenza vaccine (FLU VACCINE VII) both via unspecified routes of administration on an unspecified date in 2015 (reported as 6 years ago) at a single dose for immunization. The patient's medical history and concomitant medications were not reported. 6 years ago, after simultaneously receiving a Flu vaccine and a Pneumonia vaccine administered by a local pharmacy, the patient developed Disseminated Granuloma annular. It took almost 9 months, until the lesions fully came out. The patient's entire body was covered by the lesions, but her face. It took almost 1 year for the lesions to fade, leaving her skin damaged in many places. She became allergic to many foods, as well as preservatives in foods and drugs. The patient is 73-years-old and was asking if the COVID Vaccine is for her. The outcome of the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 0962164
Sex: F
Age:
State: IN

Vax Date: 12/29/2020
Onset Date: 01/11/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bells Palsy; This is a spontaneous report from a contactable Other HCP (patient). A 63-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Lot # EL1284) intramuscular at single dose at left arm on 29Dec2020 16:30 for Covid-19 immunisation, administered at hospital. Medical history included hypertension, thyroid disorder, high cholesterol, fibromyalgia, allergy to sulfur drugs and codeine. The patient was not pregnant. The patient had not experienced Covid-19 prior vaccination. The patient previously took codeine and experienced drug hypersensitivity. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine. The patient experienced bells palsy on 11Jan2021. The event resulted in Emergency room/department or urgent care. The event bells palsy has been treated with steroids. Post vaccination, the patient has been not tested for COVID-19. The outcome of event was recovering.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of bells palsy cannot be excluded, considering the plausible temporal relationship. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate

Other Meds:

Current Illness:

ID: 0962165
Sex: M
Age:
State: PA

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Felt brain fatigue; Felt very hungry before dinner; On 07Jan, after breakfast I suddenly felt tired, so took a nap; During the whole day I took three naps; Had sore arm; Between 15-30 min after injection, I felt light arrhythmia twice and I tried to do deeper breath to control it. About 1.5 hours after injection, in between my pull-up exercises I felt light arrhythmia; his legs were shaking which had never happened before; This is a spontaneous report from a contactable consumer reporting for himself. A 56-years-old male patient received the first dose of bnt162b2 (BNT162B2; Lot # EL0140) vaccine , in the right arm on 05Jan2021 16:00 at single dose for Covid-19 immunisation . The patient medical history and concomitant medications were not reported. The patient experienced light arrhythmia on 05Jan2021 16:30 with outcome of recovered , his legs were shaking which had never happened before on 05Jan2021 with outcome of unknown, had sore arm on 06Jan2021 with outcome of recovered; felt brain fatigue on 07Jan2021 with outcome of recovered , , felt very hungry before dinner on 07Jan2021 with outcome of recovered , on 07Jan, after breakfast felt tired, so took a nap on 07Jan2021 with outcome of recovered , during the whole day i took three naps on 07Jan2021 with outcome of recovered. Course of the event: Between 15-30 min after injection, the patient felt light arrhythmia twice and tried to do deeper breath to control it. About 1.5 hours after injection, in between his pull-up exercises he felt light arrhythmia 2-3 times, and after doing the third set of pull-ups his legs were shaking which had never happened before. Next morning the patient woke up a couple hours later than his normal time. Noting that the night before he went to bed one hour earlier for no reason. When semi-waking up, he had a strong arrhythmia, followed by a couple more light ones. In the past arrhythmia did occur to him when he was very stressed or very tired, but had not have it for a few years. The patient had sore arm but tolerable. On 07Jan2021, after breakfast the patient suddenly felt tired, so took a nap. During the whole day he took three naps, which he had never done before. No arrhythmia though. The patient felt brain fatigue, but physically no problem. He felt very hungry before dinner, same as the day before, but not in other days.

Other Meds:

Current Illness:

ID: 0962166
Sex: F
Age:
State: FL

Vax Date: 10/29/2020
Onset Date: 11/01/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data:

Allergies:

Symptoms: double ear infection; double ear infection; sinus infection; This is a spontaneous report from a contactable pharmacist. A 44-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, lot number: DJ7721, expiration date 31Jul2022), via an unspecified route of administration on 29Oct2020 at 0.5 mL, single for immunization. There were no medical history and concomitant medications. On 12Nov2020, two weeks later the patient developed the double ear infection and also experienced sinus infection on Nov2020. She had to go to the Emergency room for the double ear infection. So, the pharmacist said it was serious in her opinion. The sinus infection went away, but then she got the second double ear infection. The patient got the Prevnar 13 vaccine because she was getting a cochlear implant, and it was recommended by the surgeon. The patient said nothing else had changed except that she got the vaccine two weeks to the day of the side effects. The outcome of the event sinus infection was recovered while not recovered for the double ear infection. No follow-up attempts are needed. No further information is expected.; Sender's Comments: The association between the event lack of effect (ear infection) with PREVNAR 13 can not be fully excluded.

Other Meds:

Current Illness:

ID: 0962167
Sex: F
Age:
State: NY

Vax Date: 01/02/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210104; Test Name: covid virus test; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: she tested positive for the covid virus; she tested positive for the covid virus; her arm barely hurt (injection site); This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number unknown), via an unspecified route of administration in the arm on 02Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received her first Pfizer covid vaccine dose on 02Jan2021. She gets tested regularly at work. On 04Jan2021, she tested positive for the Covid virus. She had a headache, not feeling great on Friday, after she was diagnosed with the Covid virus, but no symptoms before. No side effects from vaccine, other than her arm barely hurt (injection site) in Jan2021. The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962168
Sex: F
Age: 24
State: IL

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: No

Allergies: No

Symptoms: 8 minutes after being vaccinated pt had extreme anxiety with heart palpitations. Hx of passing out after shots, vitals - nl. Exam - unremarkable Plan observe and home. Unlikely to be allergic Rx

Other Meds: No

Current Illness: No

ID: 0962169
Sex: M
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 01/21/2021
Hospital: Y

Lab Data: Test Date: 202101; Test Name: Fibrin D dimer; Result Unstructured Data: Test Result:high

Allergies:

Symptoms: Clotting event; Fibrin D dimer high; chest pains; Little injection site soreness; This is a spontaneous report from a contactable consumer reporting for himself. A male patient of an unspecified age received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer -BioNTech), via an unspecified route of administration in the arm, on 22Dec2020, at single dose, for COVID-19 immunisation. Medical history was none. Concomitant medications were not reported. The patient experienced fibrin d dimer high in Jan2021 with outcome of unknown, clotting event on 03Jan2021 with outcome of unknown, chest pains on 03Jan2021 with outcome of unknown, little injection site soreness on 22Dec2020 with outcome of unknown. The events fibrin D dimer high and clotting event caused patient's hospitalization in Jan2021. The patient underwent lab tests and procedures which included fibrin d dimer: high in Jan2021. The patient was vaccinated on 22Dec2020 close to the evening and had a normal response with a little soreness in the arm at the injection site. Then on 03Jan2021, he reported to be having chest pains that he never had before and went to the emergency department (ED) due to a clotting event. Upon blood work, they discovered that his D-dimer was elevated and was really high for his age. He mentioned that he had no history and no issues with this whatsoever before. He received the 2nd dose on 11Jan2021. The information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0962170
Sex: F
Age:
State: FL

Vax Date: 09/21/2020
Onset Date: 09/22/2020
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Name: chest scans; Result Unstructured Data: Test Result:Unknown results; Test Name: MRI; Result Unstructured Data: Test Result:Unknown results; Test Name: head scans; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: headache; This is a spontaneous report from a contactable consumer. An 80-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on the left arm on 21Sep2020 at a single dose for immunization and influenza vaccine (FLU VACCINE), via an unspecified route of administration on the right arm on 21Sep2020 at an unspecified dose for immunization. Medical history included pneumonia from an unknown date and unknown if ongoing. There were no concomitant medications. It was reported that the patient received the pneumococcal 13-valent conjugate vaccine and flu vaccine 21Sep2020 and on 22Sep2020, the patient has had a headache ever since. She wanted to know what she can do about the headache and is it safe to take the COVID-19 vaccine or wait until the headaches stops. She has had this headache since she got the pneumococcal 13-valent conjugate vaccine and she has seen several doctors and had a MRI, she's had head scans and chest scans and everything they could think of, the doctors are stumped. Sometimes, she takes Advil and it will go away sometimes it will not go away. She was wondering if others have had that experience and what they have done about it. She does not have any dose information for the pneumococcal 13-valent conjugate vaccine. She said it was the first dose of pneumococcal 13-valent conjugate vaccine. She understands there are 2, you get the first one and later you get a second one. When asked for the indication, she stated that with the COVID virus many people her age was dying from pneumonia. She had pneumonia 40 years ago so she figured it would be a good idea to get the pneumonia vaccine first and then see if it is compatible with the COVID vaccine but she does not want to get the COVID vaccine if she still has a headache. She did not know what the name of the flu vaccine was. She just knew they gave the flu vaccine in the right arm and pneumococcal 13-valent conjugate vaccine in the left arm and she said they would not counteract each other, they were safe, so she took her word for it. Indication for flu vaccine: The doctor wanted her and her husband to get it, he is 88 and she is 80 so the doctor wanted them to get it to protect them through the winter. He wanted them to get it in Sep before the flu season hit. No further information provided. She says there is no other medicines medical conditions or lab results to add. That is what has stumped her. She has been in excellent health for her age. The outcome of the event was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0962171
Sex: F
Age:
State: TX

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Lab Data: Test Date: 20210110; Test Name: fever; Result Unstructured Data: Test Result:99.9 Fahrenheit

Allergies:

Symptoms: Low grade fever (99.9) body aches, nerve pain chills, headache, ear pain; Low grade fever (99.9) body aches, nerve pain chills, headache, ear pain; Low grade fever (99.9) body aches, nerve pain chills, headache, ear pain; Low grade fever (99.9) body aches, nerve pain chills, headache, ear pain; Low grade fever (99.9) body aches, nerve pain chills, headache, ear pain; Low grade fever (99.9) body aches, nerve pain chills, headache, ear pain; This is a spontaneous report from a contactable Nurse (patient). A 51-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number El3248), via an unspecified route of administration in the left arm on 09Jan2021 06:30 at single dose for COVID-19 immunisation at hospital. Medical history included asthma, seasonal allergy, milk allergy, eucalyptus allergy. Concomitant medication included montelukast sodium (SINGULAIR), levocetirizine dihydrochloride (XYZAL), ciclosporin (RESTASIS, eye drop). The patient previously took tetanus vaccine and experienced drug hypersensitivity. The patient experienced low grade fever (99.9 F) body aches, nerve pain chills, headache, ear pain on 10Jan2021 08:00 with outcome of recovered. The patient took diphenhydramine hydrochloride (BENADRYL) 25mg every 6 hours and it relieved all symptoms. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination the patient had not been tested for COVID-19.

Other Meds: SINGULAIR; XYZAL; RESTASIS

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm